LATEST

• REGULATORY MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?
  December 4, 2025

• REGULATORY Bayer’s Eylea Bio-AG Finally Reaches NHI Listing amid Reform Talks
  December 4, 2025

• REGULATORY MHLW Panel Green-Lights Approval for Kissei’s Uterine Fibroid Drug, 3 More NMEs
  December 4, 2025

• REGULATORY MHLW Proposes Pricing New AGs and Bio-AGs on Par with Originators
  December 4, 2025

• REGULATORY FY2026 Reform Roadmap Keeps Key Drug Pricing Issues on Ice, Snubs Many Industry Requests: Chuikyo
  December 4, 2025

• BUSINESS Novo Nordisk Launches Higher-Capacity Awiqli Pen in Japan
  December 4, 2025

• BUSINESS Daiichi Sankyo Wins US Appeal in Seagen ADC Patent Dispute
  December 4, 2025

• BUSINESS Vimpat Generics Win Added Use, Clearing Path for Full-Label Launch
  December 4, 2025

• REGULATORY LDP Tax Panel Puts R&D Tax Credit on Political-Judgment Track for Further Talks
  December 3, 2025

• ORGANIZATION Labor Union Group Submits Request, Urges Drug Pricing Overhaul amid Inflation
  December 3, 2025

• REGULATORY Average NHI-Market Price Gap Hits Fresh Record Low at 4.8%
  December 3, 2025

• REGULATORY MOF Panel Submits Budget Proposal, Urges Wider CEA Use and More Frequent Re-Pricing
  December 3, 2025

• BUSINESS Alfresa, CMIC Ink Pact to Build Vaccination Support Platform
  December 3, 2025

• BUSINESS Lundbeck Japan Plans to Double Workforce by 2028 as It Eyes 3 Drug Approvals
  December 2, 2025

• BUSINESS Sawai Eyes Digital and Device Business as Next Growth Pillar after Generics
  December 2, 2025

• BUSINESS Mochida Launches Mochi-Gel Cartilage Repair Device, a First for Japan
  December 2, 2025

• BUSINESS Shionogi Completes Takeover of JT’s Pharma Business
  December 2, 2025

• BUSINESS EMA Starts Review of Padcev-Keytruda for Perioperative Bladder Cancer
  December 2, 2025

• ACADEMIA Early CGP Testing Cuts Mortality Risk by 41%, Research Shows
  December 1, 2025

• BUSINESS Japan’s Prescription Drug Market to Near 12 Trillion Yen in FY2030: IQVIA
  December 1, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• Next ›
• 最終 »